Aytac Gulcu

Aytac Gulcu

Auto-generated profile, based on publicly available information

Aytac Gulcu

Faculty of Medicine, Department of Radiology Dokuz Eylül University İzmir Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2021 in Rheumatology
Verified
Journal Article
Closed access
BKBelde Kasap-Demir
Belde Kasap-Demir
ASAlper Soylu
Alper Soylu
AGAytaç Gülcü
Aytaç Gülcü
YGYiğit Göktay
Yiğit Göktay
MTMehmet Atilla Türkmen
Mehmet Atilla Türkmen
SKSalih Kavukçu
Salih Kavukçu

29 March 2026 in Clinical Case Reports
Verified
Journal Article
Open access
ACAras Emre Canda
Aras Emre Canda
SASemra Demirli Atici
Semra Demirli Atici
AGAytac Gulcu
Aytac Gulcu
Ectopic variceal bleeding is a rare but life‐threatening complication of portal hypertension. For severe parastomal variceal hemorrhage unresponsive to conservative therapy, endovascular embolization is a safe, minimally invasive, repeatable, and effective life‐saving alternative, particularly in patients with portal hypertension and hepatic dysfunction.

5 April 2026 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
SYSerife Ozturk Yilmaz
Serife Ozturk Yilmaz
AYAyca Yigit
Ayca Yigit
SHSevcan Hatipoglu
Sevcan Hatipoglu
SGSemra Gürsoy
Semra Gürsoy
AGAytac Gulcu
Aytac Gulcu
OBOzlem Giray Bozkaya
Ozlem Giray Bozkaya

31 January 2025 in Journal of Basic and Clinical Health Sciences
Verified
Journal Article
Open access
PDF file
SDSüleyman DOLU
Süleyman DOLU
GBGöksel Bengi
Göksel Bengi
NDNilay Danis
Nilay Danis
MSMüjde Soytürk
Müjde Soytürk
IBİlKer Büyüktorun
İlKer Büyüktorun
ÖTÖmer Selahattin Topalak
Ömer Selahattin Topalak
Background and Purpose: Partial splenic embolization is a common treatment for hypersplenism in patients with cirrhosis. In this investigation, we evaluated the effectiveness and safety of partial splenic embolization in patients with cirrhosis. Methods: We retrospectively investigated 17 patients with hypersplenism secondary to cirrhosis who underwent partial splenic embolization. Following partial splenic embolization, peripheral blood cell counts were measured at regular intervals over a period of twelve months.Post-procedural complications were recorded. Results: This study included 17 individuals, with a mean age of 54.5 ± 10 years. Hemoglobin, platelet, neutrophil, lymphocyte, and white blood cell counts showed statistically significant increases.when compared to the pre-procedure levels at each time point (pre-procedure vs. 1st day p